Target intelligence / Profile preview

Cardiac preload

Molecular classification
Other (physiological parameter; not a receptor, enzyme, transporter, protein, etc.)
01

Overview

Cardiac preload describes the degree of stretch or initial tension in myocardial fibers caused by ventricular filling at the end of diastole, just before contraction. It is a determinant of stroke volume according to the Frank-Starling law: the greater the stretch (within physiological limits), the stronger the subsequent contraction. Preload is affected by blood volume, venous return, heart rate, rhythm, and ventricular compliance. Clinically, it is estimated by ventricular end-diastolic pressure or volume. Preload manipulation is important in managing fluid balance, heart failure, and shock, but it is not a discrete molecular or receptor target for drugs.

Other names
Left ventricular end-diastolic pressure (LVEDP)Ventricular end-diastolic volume (EDV)Initial myocardial stretch
02

Mechanism of action

Drugs that reduce preload generally decrease blood volume (diuretics), increase venous dilation (nitrates), or alter cardiac filling pressures; Drugs that increase preload may include fluids/blood products

03

Biological functions

Regulates stroke volume through the Frank-Starling mechanismInfluences cardiac outputDetermines ventricular contraction strength
04

Disease associations

Cardiovascular disease (e.g., heart failure, pulmonary congestion)Other (altered preload—too high or too low—has diverse pathological consequences)
05

Safety considerations

Excessive reduction: impaired organ perfusion, hypotensionExcessive increase: pulmonary edema, congestive heart failureMonitoring required in critically ill patients
06

Interacting drugs

Diuretics (reduce preload by lowering blood volume)

3 more in the full profile.

07

Biomarkers

Pulmonary artery wedge pressure (PAWP)End-diastolic volume (measured by echocardiography)Central venous pressure (CVP)

Beyond the preview

Go deeper on Cardiac preload.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiac preload.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call